External Advisory Board
Alexander A. Vinks, PharmD, PhD, FCP
Professor and Director
Pediatric Pharmacology Research Unit and
Laboratory of Applied Pharmacokinetics & TDM
Cincinnati Children's Hospital Medical Center
3333 Burnet Avenue, MLC 6018
Cincinnati, OH 45229-3039
Phone: (513) 636-0159 (direct)
(513) 636-3232 (secretary)
Fax: (513) 636-0168
Dr. Vinks is an internationally-recognized pediatric clinical pharmacologist. Likewise, he is extremely experienced in pharmacometrics and has published numerous papers on population-based PK/PD models in children. His is also a world leader in the integration of therapeutic drug monitoring to hospital-based decision support. He will be a critical component of the global appreciation of the PKB and is committed to bringing the PKB system to Cincinnati Children's Hospital where he heads the Laboratory of Applied Pharmacokinetics & TDM.
Roger W. Jelliffe, M.D.
Professor of Medicine,
Division of Geriatric Medicine,
Laboratory of Applied Pharmacokinetics,
USC Keck School of Medicine
2250 Alcazar St, Los Angeles CA 90033, USA
Phone (323)442-1300, fax (323)442-1302
Email: jelliffe@usc.edu
Web site: http://www.lapk.org
Dr. Jelliffe has been a pioneer in the area of therapeutic drug monitoring and the development of models to individualize and manage drug therapy. His efforts to define optimal gentamicin therapy and renal function relationships via surrogate markers (e.g. creatinine clearance) represent milestones in patient management directly and indirectly affecting millions of patients. Since 1966 his lab has researched optional individualization of drug dosage regimens. Since 1973 the Laboratory of Applied Pharmacokinetics has continued to investigate the optimal study and control of pharmacokinetic systems and individualized drug therapy supported in part by the National Library of Medicine (NLM) and National Center for Research Resources (NCRR) under Dr. Jelliffe's direction.
Hisakazu Ohtani, PhD,
Vice-Professor
Graduate School of Pharmaceutical Sciences
The University of Tokyo
7-3-1, Hongo, Bunkyo-ku, 113-0033
JAPAN
E-mail: ohtani@mol.f.u-tokyo.ac.jp
Facsimile (Business): +81-3-5841-1097
Phone (Business): +81-3-5841-1096
Professor Ohtani is an expert in the integration of drug information to advise patient management. He has also developed and applied an internet-based educational system (iPhiss) to share pharmaceutical case reports between pharmacists nationwide in Japan. Dr. Ohtani is also interested in the development of prediction algorithms to derive therapeutic dosing recommendations from preclinical and in vitro data, a key feature when adult data is limited, unavailable or not relevant to pediatric indications.
Trevor Johnson, PhD
Pharmacy Department, Children's Hospital
Western Bank, S10 2TH
Sheffield, UK
Email: Trevor.Johnson@sch.nhs.uk
Phone: +44-114-2717278
Fax: +44-114-2768392
Dr. Johnson is an internationally-recognized thought leader in pediatric clinical pharmacology. He has been a pioneer in the integration of CYP ontogeny information into models for predicting drug disposition in children. He also has had a pivotal role in the Paediatric module of the Simcyp ADME Population-based Simulator which seeks to facilitate the development of drugs suitable for use in children.
Mr. Jon Weisz
Director, JMP Marketing
SAS Institute Inc.
SAS Campus Drive
Cary, North Carolina 27513
USA
Ph: 919-531-3576
Fax: 919-677-4444
E-mail: Jon.Weisz@sas.com
Mr Weisz directs marketing, strategy, and product planning for the SAS JMP software. He has worked for SAS for eight years in various roles including product development, marketing and sales support. Mr Weisz has extensive industry experience in semiconductor and automotive manufacturing and product development. His industry roles also include Director of Statistical Methods at Allegro Microsystems, Inc. He will be an invaluable asset to the EAB providing critical review and guidance on systems testing, validation and production readiness of the PKB system.